CardiNor AS
https://cardinor.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From CardiNor AS
Start-Up Quarterly Statistics, Q1 2016
Start-ups raised $1.8 billion in Q1 2016. Biopharma companies penned 33 alliances; 14 acquisitions were signed (11 in the biopharma industry).
The New Norway: “More Research And More Companies” – The Inven2 View
Plummeting oil prices prompted Norway’s politicians to look at developing other industries. As a result, several programs have been launched to incentivize new areas, including biopharma and diagnostics.
Norway’s Pre Diagnostics Has Alzheimer’s Test In Its Sights
Pre Diagnostics AS is a 2.5-year-old Oslo company developing a blood-based test performed by a GP and sent to a lab for early Alzheimer’s diagnosis.
CardiNor Leads The Charge As Norway Gets Behind Life Sciences
Norwegian start-up CardiNor is developing a new cardiovascular biomarker, and is hopeful of attracting cash in a country where investor traditions are undergoing some changes. The financial pressures caused by falling oil prices have brought renewed attention to life science companies.
Company Information
- Industry
-
In Vitro Diagnostics
- Chemistry, Immunoassay
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice